Although clinicopathologic parameters, such as the tumor size, lymph node metastasis, tumor extension, and vascular invasion, were not significantly associated with HMGB1 expression, the expression of HMGB1 strongly and positively correlated with the metastatic status of patients with HCC. The gene discussed is HMGB1; the disease is hepatocellular carcinoma.